Serena Di Cosimo (S Di Cosimo)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

Cancers

The International journal of biological markers

JCO precision oncology

Cancer medicine

Fondazione IRCCS Istituto Nazionale dei Tumori

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Clinical researcher :: Department of Applied Research and Scientific Development

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Faculty :: Division of Oncology

Hospital Universitari Vall d'Hebron

Spain

Faculty :: Department of Oncology

Istituto Regina Elena

Italy

Clinical fellow :: Division of Oncology A

Publications

Serena Di Cosimo, Marco Silvestri, Cinzia De Marco, Carolina Reduzzi, Secondo Folli, Maria Carmen De Santis, Vera Cappelletti
Assessing HER2 status in breast cancer through next-generation sequencing of circulating tumor cells. The International journal of biological markers (2024)
Serena Di Cosimo, Marco Silvestri, Cinzia De Marco, Carolina Reduzzi, Secondo Folli, Maria Carmen De Santis, Vera Cappelletti
Assessing HER2 status in breast cancer through next-generation sequencing of circulating tumor cells. The International journal of biological markers 39 (2) (2024)
Serena Di Cosimo, Marco Silvestri, Cinzia De Marco, Carolina Reduzzi, Secondo Folli, Maria Carmen De Santis, Vera Cappelletti
Assessing HER2 status in breast cancer through next-generation sequencing of circulating tumor cells. The International journal of biological markers 39 (2) (2024)
Mattia Rediti, Aranzazu Fernandez-Martinez, David Venet, Françoise Rothé, Katherine A Hoadley, Joel S Parker, Baljit Singh, Jordan D Campbell, Karla V Ballman, David W Hillman, Eric P Winer, Sarra El-Abed, Martine J Piccart, Serena Di Cosimo, William Fraser Symmans, Ian E Krop, Roberto Salgado, Sherene Loi, Lajos Pusztai, Charles M Perou, Lisa Anne Carey, Christos Sotiriou
Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials. Nature communications 14 (1) (2023)
Serena Di Cosimo, Vera Cappelletti, Giancarlo Pruneri
Advancing Circulating Tumor DNA for Recurrent Breast Cancer. JCO precision oncology 7 (2023)
Serena Di Cosimo, Vera Cappelletti, Giancarlo Pruneri
Advancing Circulating Tumor DNA for Recurrent Breast Cancer. JCO precision oncology 7 (2023)
Marco Silvestri, Trung Nghia Vu, Federico Nichetti, Monica Niger, Serena Di Cosimo, Filippo De Braud, Giancarlo Pruneri, Yudi Pawitan, Stefano Calza, Vera Cappelletti
Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma. Cancer medicine (2023)
Valentina Fogazzi, Marcel Kapahnke, Alessandra Cataldo, Ilaria Plantamura, Elda Tagliabue, Serena Di Cosimo, Giulia Cosentino, Marilena V Iorio
The Role of MicroRNAs in HER2-Positive Breast Cancer: Where We Are and Future Prospective. Cancers 14 (21) (2022)
Annalisa Trama, Alice Bernasconi, Laura Botta, Serena Di Cosimo, Rosalba Miceli, Melanie Claps, Fabio Badenchini, Roberto Lillini, Massimiliano Rubino, Paolo Lasalvia
COVID-19 outbreak in Lombardy: Impact on reducing solid cancer diagnoses in 2020. International journal of cancer 151 (9) (2022)
E La Rocca, M C De Santis, M Silvestri, E Ortolan, M Valenti, S Folli, F G de Braud, G V Bianchi, G P Scaperrotta, G Apolone, M G Daidone, V Cappelletti, G Pruneri, Serena Di Cosimo
Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNA. Journal of cancer research and clinical oncology 148 (6) (2022)
Serena Di Cosimo, Barbara Tagliaferri, Daniele Generali, Fabiola Giudici, Francesco Agustoni, Antonio Bernardo, Karen Borgonovo, Gabriella Farina, Giovanna Luchena, Andrea Luciani, Franco Nolè, Laura Palmeri, Filippo Pietrantonio, Guido Poggi, Paolo Andrea Zucali, Emanuela Balletti, Giovanna Catania, Ottavia Bernocchi, Federica D'Antonio, Monica Giordano, Francesco Grossi, Angioletta Lasagna, Nicla La Verde, Mariangela Manzoni, Benedetta Montagna, Angelo Olgiati, Alessandra Raimondi, Irene Rampinelli, Elena Verri, Alberto Zaniboni, Massimo Di Maio, Giordano Beretta, Marco Danova
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study. Cancers 13 (6) (2021)
Giancarlo Feliciello, Serena Di Cosimo, Lorenzo Gerratana, Rosita Motta, Antonia Martinetti, Andrea Vingiani, Paolo D'Amico, Youbin Zhang, Marta Vismara, Catherine Depretto, Gianfranco Scaperrotta, Secondo Folli, Giancarlo Pruneri, Massimo Cristofanilli, Maria Grazia Daidone, Vera Cappelletti
Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer. Cancers 13 (10) (2021)
Tiziana Triulzi, Giampaolo Bianchini, Serena Di Cosimo, Tadeusz Pienkowski, Young-Hyuck Im, Giulia Valeria Bianchi, Barbara Galbardi, Matteo Dugo, Loris De Cecco, Ling-Ming Tseng, Mei-Ching Liu, Begoña Bermejo, Vladimir Semiglazov, Giulia Viale, Juan de la Haba-Rodriguez, Do-Youn Oh, Brigitte Poirier, Pinuccia Valagussa, Luca Gianni, Elda Tagliabue
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial. Molecular oncology (2021)
Sara Pizzamiglio, Giulia Cosentino, Chiara M Ciniselli, Loris De Cecco, Alessandra Cataldo, Ilaria Plantamura, Tiziana Triulzi, Sarra El-Abed, Yingbo Wang, Mohammed Bajji, Paolo Nuciforo, Jens Huober, Susan L Ellard, David L Rimm, Andrea Gombos, Maria Grazia Daidone, Paolo Verderio, Elda Tagliabue, Serena Di Cosimo, Marilena V Iorio
What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study. Cancer medicine 11 (2) (2021)
Andrea Malfettone, Serena Di Cosimo, José Manuel Pérez-García, Alicia García, Miguel Sampayo-Cordero, Leonardo Mina, Carolina Herrero, Antonio Llombart-Cussac, Javier Cortes
Nobody dares stopping clinical research, not even COVID-19. NPJ breast cancer 7 (1) (2021)
Elena López-Miranda, José Manuel Pérez-García, Serena Di Cosimo, Etienne G C Brain, Maja Ravnik, Santiago Escriva-de-Romani, María Jesús Vidal Losada, Joseph Gligorov, Simona Borštnar, Laura Calabuig, Miguel Sampayo-Cordero, Andrea Malfettone, Antonio Llombart-Cussac, Thomas M Suter, Javier Cortés
Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial. Cancers 12 (12) (2020)
M C De Santis, E La Rocca, E Meneghini, G Bregni, G Di Lorenzo, G Galli, M Di Nicola, S Folli, M Gennaro, G Pruneri, B Paolini, M G Daidone, F De Braud, G Apolone, M Sant, Serena Di Cosimo
Axillary nodal involvement by primary tumor features in early breast cancer: an analysis of 2600 patients. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (5) (2019)

Serena Di Cosimo (S Di Cosimo)

Publication Activity (10 Years)

Top Topics

Top Venues